INVO Bioscience, Inc. Profile
Industry
Medical - DevicesSector
HealthcareNumber of Employees
15INVO Bioscience's Business Model
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
About INVO Bioscience
Website: https://www.invobio.com
CEO (Chief Executive Officer): Mr. Steven M. Shum
IPO date: 2020-11-02
Contact
Country: US
Address: 5582 Broadcast Court
City: Sarasota
State: FL
Phone: 978 878 9505
Zip Code: 34240
Other
CIK: 0001417926
ISIN: US44984F4019
CUSIP: 44984F302
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.